Hepatobiliary Surgery Practice Questions

Q: What is the type of this shunt?

Selective shunt. ***Selective shunt*** - The **distal splenorenal (Warren) shunt** selectively decompresses **esophageal varices** via the splenic vein while preserving portal hypertension to maintain **hepatopetal flow** to the liver. - This selective approach reduces the risk of **hepatic encephalopathy** by maintaining liver perfusion and function compared to non-selective shunts. *Non-selective shunt* - **Portacaval** and **mesocaval shunts** decompress the entire portal system, leading to loss of **hepatopetal flow** and increased risk of encephalopathy. - These shunts redirect all portal blood away from the liver, causing **hepatic dysfunction** and poor long-term outcomes. *None of the above* - This option is incorrect as **selective shunt** accurately describes the distal splenorenal shunt's mechanism. - The classification system for **portosystemic shunts** clearly includes selective, non-selective, and partial categories. *Partial shunt* - **Partial shunts** like small-diameter **H-grafts** reduce portal pressure while maintaining some hepatopetal flow, but this is not the primary classification for Warren shunt. - The Warren shunt is specifically designed for **selective decompression** rather than partial flow reduction.

Q: Which of the following is NOT true of cholelithiasis?

Ileal resection has no effect on gallstone formation.. **Explanation:** The correct answer is **D**, as ileal resection is a well-known risk factor for the development of gallstones. **1. Why Option D is the correct choice (The "False" statement):** The terminal ileum is the primary site for the reabsorption of **bile salts** (enterohepatic circulation). When the ileum is resected or diseased (e.g., Crohn’s disease), the bile salt pool is depleted. Since bile salts are essential for keeping cholesterol in a soluble state, their deficiency leads to **supersaturation of bile with cholesterol**, resulting in the formation of cholesterol gallstones. **2. Analysis of other options:** * **Option A:** Biliary fistulas (e.g., cholecystoduodenal fistula) occur when a large stone causes pressure necrosis of the gallbladder wall and an adjacent organ. This can lead to **gallstone ileus**. * **Option B:** Cholelithiasis follows the classic "4 F's" rule: **F**emale, **F**at, **F**ertile, and **F**orty. Estrogen increases cholesterol secretion into bile, making it more lithogenic. * **Option C:** Clofibrate (and other fibrates) inhibits the enzyme *7-alpha-hydroxylase*, reducing bile acid synthesis and increasing biliary cholesterol excretion, thus predisposing to stones. **Clinical Pearls for NEET-PG:** * **Most common type of stone:** Mixed stones (globally), though cholesterol stones are common in the West. * **Black Pigment Stones:** Associated with chronic hemolysis (e.g., Hereditary Spherocytosis, Sickle Cell Anemia) and cirrhosis. * **Brown Pigment Stones:** Associated with biliary stasis and infection (e.g., *E. coli*, *Ascaris lumbricoides*). * **Investigation of Choice:** Ultrasonography (USG) is the gold standard for diagnosis.

Q: All of the following are associated with Caroli's disease, EXCEPT:

Biliary atresia. **Explanation:** **Caroli’s Disease** is a rare congenital disorder characterized by multifocal, segmental saccular dilatation of the large intrahepatic bile ducts. It is classified as a **Todani Type V choledochal cyst**. **Why Biliary Atresia is the Correct Answer:** Biliary atresia involves the fibro-obliterative destruction of the extrahepatic biliary tree, leading to obstruction. In contrast, Caroli’s disease is a condition of **ductal ectasia (dilatation)**. There is no established pathophysiological link between the two. Caroli’s disease is more commonly associated with **Autosomal Recessive Polycystic Kidney Disease (ARPKD)** and congenital hepatic fibrosis (known as Caroli’s Syndrome). **Analysis of Incorrect Options:** * **Biliary Lithiasis:** Stasis of bile within the dilated intrahepatic saccules leads to the formation of "sludge" and hepatolithiasis (intrahepatic stones) in up to 95% of patients. * **Biliary Abscess:** Recurrent bouts of bacterial cholangitis due to bile stasis and stone formation frequently progress to the formation of multiple intrahepatic biliary abscesses. * **Cholangiocarcinoma:** Chronic inflammation and irritation of the biliary epithelium pose a significant premalignant risk. Patients with Caroli’s disease have a 7–15% lifetime risk of developing cholangiocarcinoma. **NEET-PG High-Yield Pearls:** * **Genetics:** Associated with the **PKHD1** gene mutation. * **Imaging Gold Standard:** MRCP is the investigation of choice; it shows the **"Central Dot Sign"** (portal vein branches surrounded by dilated bile ducts) on CT/MRI. * **Classification:** Caroli’s Disease (limited to bile ducts) vs. Caroli’s Syndrome (bile duct dilatation + congenital hepatic fibrosis/portal hypertension). * **Treatment:** Localized disease is treated with lobectomy; diffuse disease requires liver transplantation.

Q: All are indicators of active bleeding from varices during endoscopy, EXCEPT:

Yellow nipple. **Explanation:** In the management of portal hypertension and variceal hemorrhage, identifying "stigmata of recent hemorrhage" (SRH) during endoscopy is crucial for diagnosis and therapeutic intervention. **Why "Yellow Nipple" is the correct answer:** There is no clinical entity known as a "yellow nipple" in the context of variceal bleeding. This is a distractor option. The term likely mimics the "White Nipple Sign," but yellow discoloration is not an indicator of active or recent variceal hemorrhage. **Analysis of Incorrect Options (Indicators of Bleeding):** * **Active bleeding (Option A):** This is the most definitive sign, characterized by "spurting" (arterial-like) or "oozing" from a varix. * **White nipple sign (Option B):** This is a high-yield finding. It represents a platelet-fibrin plug overlying a point of recent rupture. It indicates that the varix has bled recently and carries a high risk of re-bleeding if not treated. * **Clots overlying a varix (Option C):** Adherent clots (red plugs) indicate a recent site of hemorrhage where the bleeding has temporarily stopped due to clot formation. **High-Yield Clinical Pearls for NEET-PG:** * **Red Color Signs:** Other endoscopic markers of high bleeding risk include **Cherry red spots**, **Red wheals** (red wales), and **Hematocystic spots**. * **Child-Pugh Score:** The most important prognostic indicator for patients with variceal bleeding. * **Management:** The gold standard for active variceal bleeding is **Endoscopic Variceal Ligation (EVL)** combined with pharmacotherapy (Octreotide or Terlipressin). * **Prophylaxis:** Propranolol (non-selective beta-blocker) is used for primary prophylaxis to reduce portal pressure.

Q: What is the investigation of choice for choledochal cyst?

MRCP. **Explanation:** **Choledochal cysts** are congenital cystic dilatations of the biliary tree. The primary goal of imaging is to delineate the anatomy of the cyst, its extent, and the presence of an **Anomalous Pancreaticobiliary Duct Junction (APBDJ)**, which is frequently associated with this condition. * **Why MRCP is the Investigation of Choice (IOC):** Magnetic Resonance Cholangiopancreatography (MRCP) is a non-invasive, radiation-free modality that provides excellent anatomical detail of the entire biliary tree and pancreatic duct. It has a high sensitivity for detecting APBDJ and is preferred over invasive methods, especially in the pediatric population. **Analysis of Other Options:** * **USG (Ultrasound):** This is the **initial/screening investigation**. While it can detect a cyst, it is operator-dependent and often fails to visualize the distal common bile duct or the pancreaticobiliary junction clearly. * **ERCP (Endoscopic Retrograde Cholangiopancreatography):** Historically the "gold standard" for biliary anatomy, it is now reserved for **therapeutic interventions** (e.g., stone removal or stenting) due to its invasive nature and risks like pancreatitis. * **Graham Cole’s Test:** An obsolete oral cholecystography technique used historically to visualize the gallbladder; it has no role in modern biliary imaging. **High-Yield Clinical Pearls for NEET-PG:** * **Classification:** Todani’s Classification (Type I is the most common; Type V is Caroli’s Disease). * **Classic Triad:** Jaundice, right upper quadrant pain, and a palpable mass (seen in only 20% of cases). * **Treatment:** Complete surgical excision of the cyst with **Roux-en-Y Hepaticojejunostomy** (to prevent the high risk of cholangiocarcinoma). * **Gold Standard:** While MRCP is the IOC, **Intraoperative Cholangiography (IOC)** remains the most definitive way to define anatomy during surgery.

Q: Which of the following is the least common presentation of Hepatocellular Carcinoma (HCC)?

Pyrexia of Unknown Origin (PUO). **Explanation:** Hepatocellular Carcinoma (HCC) typically arises in the background of chronic liver disease or cirrhosis. While it can present with a wide array of symptoms, **Pyrexia of Unknown Origin (PUO)** is considered the **least common** presentation among the options provided. 1. **Why PUO is the correct answer:** Fever in HCC is usually a paraneoplastic manifestation or due to tumor necrosis. While it occurs in approximately 10–15% of cases, it is rarely the *sole* or primary presenting feature (PUO). Most patients present with more overt signs of malignancy or liver decompensation before a fever workup is initiated. 2. **Analysis of Incorrect Options:** * **Abdominal Mass:** This is a very common presentation, especially in non-cirrhotic patients or in regions where screening is not routine. A palpable, firm, irregular liver mass is a classic finding. * **Jaundice:** This occurs frequently due to underlying cirrhosis, biliary obstruction by the tumor, or extensive replacement of the liver parenchyma. * **Weakness:** General constitutional symptoms like fatigue, weight loss, and anorexia are the most common non-specific complaints in patients with any advanced malignancy, including HCC. **Clinical Pearls for NEET-PG:** * **Most common presentation:** Abdominal pain (right upper quadrant) and weight loss. * **Most common site of metastasis:** Lungs (hematogenous spread). * **Tumor Marker:** Alpha-fetoprotein (AFP) >400 ng/mL is highly suggestive, but it can be normal in up to 30% of cases. * **Triad of HCC:** Rapidly enlarging liver, ascites (often blood-stained), and RUQ pain. * **Auscultation:** A **bruit or friction rub** over the liver is a high-yield physical sign specific to HCC.

Q: What is the recommended timing for performing cholangiography with a T-tube after cholecystectomy?

7-10 days. **Explanation:** The correct timing for a postoperative T-tube cholangiogram is **7–10 days** after surgery. The primary medical rationale for this delay is to allow sufficient time for the **maturation of the fibrous tract** around the T-tube. If the tube is manipulated or if contrast is injected under pressure too early, there is a significant risk of bile leakage into the peritoneal cavity, leading to biliary peritonitis. By day 7–10, the tract is usually well-formed, and any residual stones in the common bile duct (CBD) can be safely identified before the tube is considered for removal. **Analysis of Options:** * **Option A (1-5 days):** Too early. The fibrous tract is immature, and the risk of bile leak is high. Additionally, postoperative edema at the Ampulla of Vater may still be present, leading to false-positive results (mimicking a stone). * **Option C & D (10-20 days):** While a cholangiogram can be performed during this window, it is not the *standard recommended timing*. Waiting until 14–21 days is typically reserved for the actual **removal** of the T-tube (to ensure a very firm tract), but the diagnostic imaging is ideally done sooner (day 7–10) to plan further management. **NEET-PG High-Yield Pearls:** * **Indications for T-tube:** Placed after a Common Bile Duct Exploration (CBDE) to provide drainage and a route for postoperative imaging. * **The "Water Test":** Before removing a T-tube, it is often clamped for 24 hours. If the patient develops pain or jaundice, it suggests distal obstruction (retained stone). * **Retained Stones:** If the cholangiogram shows a stone, the T-tube is left in place for **4–6 weeks** to allow the tract to mature enough for **Burhenne’s technique** (percutaneous stone extraction via the T-tube tract).

Question 1

What is the type of this shunt?

Accepted Answer

Selective shunt

Answer

Non-selective shunt

Answer

None of the above

Answer

Partial shunt

Question 2

Which of the following is NOT true of cholelithiasis?

Accepted Answer

Ileal resection has no effect on gallstone formation.

Answer

Biliary fistula is a complication of gallstones.

Answer

Cholelithiasis is more common in females.

Answer

Clofibrate therapy is a predisposing factor for cholelithiasis.

Question 3

All of the following are associated with Caroli's disease, EXCEPT:

Accepted Answer

Biliary atresia

Answer

Cholangiocarcinoma

Answer

Biliary lithiasis

Answer

Biliary abscess

Question 4

All are indicators of active bleeding from varices during endoscopy, EXCEPT:

Accepted Answer

Yellow nipple

Answer

Active bleeding from a varix

Answer

White nipple overlying a varix

Answer

Clots overlying a varix

Question 5

Bile strictures are most commonly seen in which of the following conditions?

Accepted Answer

Cholelithiasis

Answer

Malignancy

Answer

Post-operative state

Answer

Worm infestation

Question 6

What is the investigation of choice for choledochal cyst?

Accepted Answer

MRCP

Answer

Graham chole's test

Answer

ERCP

Answer

USG

Question 7

Mirizzi syndrome is characterized by all the following except:

Accepted Answer

Obstructive jaundice

Answer

Gallstone ulcerating into the common duct

Answer

Impacted stone in the cystic duct

Answer

Severe pericholecystic inflammation

Question 8

Which part of the intrahepatic bile duct is involved in Type 2 cholangiocarcinoma?

Accepted Answer

Division of both ducts and not extending outside

Answer

Common hepatic duct only

Answer

Secondary hepatic ducts

Answer

Extends beyond hilum

Question 9

Which of the following is the least common presentation of Hepatocellular Carcinoma (HCC)?

Accepted Answer

Pyrexia of Unknown Origin (PUO)

Answer

Abdominal Mass

Answer

Jaundice

Answer

Weakness

Question 10

What is the recommended timing for performing cholangiography with a T-tube after cholecystectomy?

Accepted Answer

7-10 days

Answer

1-5 days

Answer

10-14 days

Answer

15-20 days

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?